Pacira Pharmaceuticals stock hits 52-week high at 36.32 USD

Sterlite Technologies shares hit a 5% upper circuit after unveiling ambitious FY29 growth targets, including Rs 20,000 crore revenue and global top-five positioning. The company approved Rs 3,000 crore capex to expand capacity by 50%, supported by strong optical connectivity demand, AI infrastructure growth and a record order book.

Strong domestic formulations, chronic therapies, new US launches and a complex-product pipeline have supported the rally, though valuations now stand above historical averages

Issues notice to Nirmal Society secy after earlier proceedings found his allegations against a judge unsupported by evidence